New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine

New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine

Researchers are looking into whether high doses of famotidine could be used to treat COVID-19 patients.br Business Insider reports that Famotidine is the active ingredient in the heartburn medication Pepcid.br A clinical trial is currently underway, with researchers aiming to recruit 1,200 patients.br The trial is investigating if high doses of famotidine help critically ill coronavirus patients survive.br Researchers are using a dose that's nine times the amount of famotidine typically used to treat heartburn.br Researchers note that there's no evidence yet from the trial that suggests famotidine is helping.


User: Wochit Entertainment

Views: 14

Uploaded: 2020-04-27

Duration: 00:32

Your Page Title